-- 傑富瑞(Jefferies)週四發布的一份報告指出,由於中東衝突持續,航空公司面臨燃油成本上漲的困境,奧克蘭國際機場(ASX:AIA,NZE:AIA)的客運量預期復甦速度受到衝擊。 這家股票研究公司表示,由於燃油成本高企,多家航空公司已削減運力,奧克蘭機場第四季的國際航班座位運力也因此下降,座位成長率從2月的8.5%放緩至1%。 傑富瑞表示:「鑑於中東衝突仍在持續,我們認為目前國際運力成長計畫(2027年上半年)存在下行風險,預計成長率將為4.2%。」報告也指出,面對燃油價格上漲帶來的現金流和資產負債表壓力,航空公司可能會採取運力控制和定價策略來保護利潤率。 傑富瑞將奧克蘭國際機場2026財年的客運量預測下修0.5%,2027財年調降2.5%,2028財年調降3%。 傑富瑞將奧克蘭國際機場的目標股價從8.64紐西蘭元下調至8.49紐西蘭元,但維持「持有」評級。傑富瑞表示,自2月下旬以來,該公司股價表現遜於產業和市場整體水平,這種表現已經過頭。
Related Articles
National Australia Bank Shares Down After Resolution of Union Court Proceedings
National Australia Bank (ASX:NAB) shares were down about 1% in recent Monday trade following a Friday settlement with the Finance Sector Union of Australia to resolve court proceedings related to excessive additional working hours for employees.The settlement, reached on a without-admissions basis through mediation, includes the establishment of a health, safety, and well-being framework to mitigate the risks linked to working additional hours, and calls for greater oversight of such risks.The union and the bank said in a joint statement that they are "committed to continuing to work together to ensure fair and sustainable outcomes for all [National Australia Bank] employees."
Clinuvel Pharmaceuticals Says FDA Removes Post-Authorization Requirement for Implant
Clinuvel Pharmaceuticals (ASX:CUV) said the US Food and Drug Administration (FDA) removed a requirement for a post-authorization phase one study on cardiac repolarization in relation to its Scenesse implant upon reviewing its long-term safety profile, according to a Monday filing with the Australian bourse.Scenesse is used to treat patients with erythropoietic protoporphyria, a disease that causes intolerance to light.The FDA concluded that the study was no longer needed since it would not yield valuable safety information, the filing said.
XRF Scientific Completes Acquisition of Combustion Gas Analysis Business
XRF Scientific (ASX:XRF) has completed the acquisition of the combustion gas analysis business from Bruker AXS, according to a Monday Australian bourse filing.The company entered a binding agreement to acquire the combustion gas analysis business for $4 million upfront plus a potential $1 million earnout based on 7% of net revenue over three years, an earlier filing showed.